Interview, Fireside Chat, Other
Cognitive Decline Expert: The Disease That Starts in Your 30s but Kills You in Your 70s
- Alzheimer's disease is predicted to generally begin in the 30s with symptoms appearing in the late 60s, 70s, or beyond; current cases number 60 million (70% women), with projections indicating a tripling to 110 million cases by 2050, of which 95% are expected to be preventable through lifestyle changes as genetics account for only 3% of cases.
- Women face elevated risks due to the menopausal shift and estrogen decline starting around age 30, with the APOE4 gene raising risk by 2-3 times generally but 6-fold for one copy and 15-fold for two copies in females; the disease is described as currently having no cure once diagnosed, often leading to death from asphyxiation or falls.
- Prevention strategies emphasize midlife as a critical window for intervention, requiring 150 to 300 minutes of moderate to vigorous physical activity weekly, specifically utilizing resistance training at 80% of one repetition max and high-intensity intervals like the Norwegian 4x4 protocol to boost VO2 Max, which the speaker expects can reverse heart aging by 20 years if started before age 65.
- Sedentary behavior is identified as a major risk factor, with risks increasing if sitting exceeds 10 hours daily; compensation is recommended via 10 air squats performed every hour or every 45 minutes to outweigh the benefits of standard walking and mitigate cardiovascular disease risks.
- Cognitive and metabolic management involves a ketogenic diet to address glucose metabolism deficits during perimenopause, blood pressure control strictly below 120/80 (above 135 systolic breaks down the blood-brain barrier), and the use of high-dose creatine (up to 30 grams daily) to protect against concussions, stroke, stress, and sleep deprivation, while ensuring Omega-3 supplements are stored in the fridge to prevent oxidation.
- Specific biomarkers including tau protein, p-tau-217, and amyloid beta can now be detected in blood work with 90% accuracy, while Vitamin D levels of 60 ng/dL may lower Alzheimer's risk by 80% compared to a 40% increased risk for deficiency.
- Sleep optimization is required to prevent amyloid accumulation, involving core body temperature reduction of at least two degrees via glycine, downregulation of the nervous system with red light and GABA, and the use of adaptogens like Ashwagandha to stabilize cortisol; one night of deprivation is predicted to raise amyloid beta risk by 4-5%.
- Hormone Replacement Therapy (HRT) is predicted to reduce Alzheimer's risk by up to 30% and alleviate sleep issues via hot flash reduction, potentially reversing the 30% drop in brain glucose metabolism seen during perimenopause, despite mixed historical evidence regarding hormone therapy and breast cancer.
- Psychological resilience and "cognitive reserve" are built through "hard things" and challenging the brain to expand the anterior mid-cingulate cortex, whereas sedentary avoidance leads to atrophy; the speaker also notes a linear negative association between dietary creatine intake and cancer prevalence, with risk decreasing by 5-18% per standard deviation increase, particularly in adults over 50.